Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

Explore clinical trials studying Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer trial results

Active, Not Recruiting

A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer

NCT05297890

Conditions: Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
Locations: Guangdong Provincial People's hospital Guangzhou, Guangdong, China

Beijing Cancer Hospital Beijing, China

Cancer Hospital Chinese Academy of Medical Sciences Beijing, China

The First Hospital of Jilin University Changchun, China

View all 31 locations

View Trial Details